MEG3 and neuroblastoma: To determine whether GTL2 promoter DMR hypermethylation was associated with epigenetic alterations at the upstream IG-DMR, we analysed the methylation status of the eight CpGs within the IG-DMR in four normal control DNAs and in four neuroblastoma cell lines with 5′ GTL2 DMR methylation.